$MRK Headlines Novartis divestiture move expected, but

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2014 at 9:52 AM

$MRK Headlines

Novartis divestiture move expected, but with another partner, analyst says 12:52 p.m. April 22, 2014 - blogs.marketwatch.com
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
5 mid-cap stocks that insiders love 12:10 p.m. April 17, 2014 - Insider Monkey
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Merck rises 1.5% to lead Dow gainers 9:33 a.m. April 10, 2014 - William L. Watts
Cisco, Merck, Visa lead Dow gainers 9:32 a.m. April 9, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
The market’s rigged, you say? When wasn’t it? 12:03 p.m. April 3, 2014 - David Weidner
3 red-hot investment opportunities 8:40 a.m. April 3, 2014 - Jeff Reeves
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
Microsoft, Merck lead early Dow gainers 9:32 a.m. March 28, 2014 - William L. Watts
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Investors may need to go long if they hope to reap Baxter spinoff rewards 11:40 a.m. March 27, 2014 - blogs.marketwatch.com
Merck, Glaxo delay helping Affordable Care co-pays 4:33 p.m. March 26, 2014 - MarketWatch.com
Germany's Merck to propose 2-for-1 stock split 12:26 p.m. March 26, 2014 - MarketWatch.com
Merck, Cisco lead Dow gainers 9:33 a.m. March 26, 2014 - William L. Watts
3M, Merck lead Dow gainers 9:34 a.m. March 25, 2014 - William L. Watts
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
A tax-friendly alternative to municipal bonds 5:00 a.m. Feb. 27, 2014 - Amit Chopra

5 Dow Stocks Seeing an Outstanding 2014 8:04 a.m. Today - Wall St. Cheat Sheet
Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. Today - 247WallSt.com
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. Today - TheStreet.com
Is The Vanguard High Dividend Yield ETF Primed For Dividend Growth? 6:04 p.m. April 25, 2014 - Seeking Alpha
Week Ahead: April Jobs Report, FOMC Meeting and Earnings 4:39 p.m. April 25, 2014 - FOXBusiness
Q1 Earnings: A Stronger Weakling than Originally Thought - Earnings Preview 5:32 a.m. April 25, 2014 - Zacks.com
Costly Hepatitis Drugs Vex Prisons 5:23 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013 6:00 a.m. April 24, 2014 - TheStreet.com
Gilead, Illumina Q1 Earnings Win Wall Street's Love 10:39 a.m. April 23, 2014 - Investors Business Daily
Stock Market News for April 23, 2014 - Market News 10:06 a.m. April 23, 2014 - Zacks.com
UBS Top Stocks to Buy Working for Cancer Cures 7:52 a.m. April 23, 2014 - 247WallSt.com
Global Drug Industry Does About-Face 10:12 p.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Drugmakers Prod European Stocks To Post-Easter Rally 5:36 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Valeant Bids For Allergan 4:50 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Lilly Buying Animal Biz 10:49 a.m. April 22, 2014 - Investors Business Daily
Stock Market News for April 22, 2014 - Market News 10:06 a.m. April 22, 2014 - Zacks.com
Glaxo Exits Cancer Drugs 8:19 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Big Brands to Be United in Joint Venture 5:08 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Is Pfizer a Good Portfolio Play? 5:40 p.m. April 21, 2014 - Wall St. Cheat Sheet
Merck & Co Inc (MRK): Today's Featured Health Care Winner 5:00 p.m. April 21, 2014 - TheStreet.com

Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 12:00 p.m. April 25, 2014 - Marketwire
EMD Serono Presents New Data on Rebif® (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting 9:00 a.m. April 25, 2014 - PR Newswire - PRF
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Chugai Pharma USA Announces Appointment of Chief Medical Officer 2:00 a.m. April 25, 2014 - PR Newswire - PRF
Fitch Affirms Merck & Co.'s Long-term IDR at 'A+'; Outlook Remains Negative 2:24 p.m. April 24, 2014 - BusinessWire - BZX
Global NGO Project HOPE Launches Education Initiative on HPV Infection Prevention in China 9:28 a.m. April 24, 2014 - GlobeNewswire
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 1:13 p.m. April 23, 2014 - Marketwire
Edward S. Horton, MD, Receives American Diabetes Association's Albert Renold Award 1:12 p.m. April 23, 2014 - Marketwire
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
Merck and Award-Winning Actress S. Epatha Merkerson Challenge Americans with Type 2 Diabetes to Get to Their Goals 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Oral Hygiene Market in the United Kingdom to 2017: Market Size, Distribution and Brand Share, Key Events and Competitive Landscape 12:45 p.m. April 22, 2014 - PR Newswire - PRF
Merck among NASA Cargo Launching to Space Station 4:15 p.m. April 21, 2014 - PR Newswire - PRF
FDA Approves Merck’s RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults 6:22 p.m. April 17, 2014 - BusinessWire - BZX
Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal 12:37 p.m. April 17, 2014 - PR Newswire - PRF
Brain Cancer Global Clinical Trials Review, H1, 2014 12:25 p.m. April 17, 2014 - PR Newswire - PRF
Physicians Interactive's Transformative Omnio Medical App Expands from iPad to iPhone, Android Versions 7:54 a.m. April 16, 2014 - PR Newswire - PRF
Global Veterinary Vaccines Industry 12:06 p.m. April 15, 2014 - PR Newswire - PRF
Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch 8:00 a.m. April 15, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling Preps for Q3 2026 Financial Results Call

Anticipation Builds for Borr Drilling's Q3 Reveal Sit tight, investors. Borr Drilling Limited is set to drop its Q3 2026 financial results soon—right in the sweet spot post-market close on November 18. These moments are where fortunes are made or broken, and Borr's gearheads better be ready to spill the beans on how their offshore ventures fared in the rocky sea of...

Odessa Water Overbilling Lawsuit Surges Ahead

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Balancing Rigor and Interests in Education: Insights

Education: A Balancing Act of Academics and Interests So here's the deal, folks. Education isn't just about hitting the textbooks and acing exams. It's a wild dance—balancing rigorous academics and the extracurricular hustle. Brent Reckman, the brains behind The Academy of Charter Schools in Westminster, Colorado, knows this orchestra well. In a feature with...

Fitness Career Platform's Big Ramp Up Sparks Buzz

ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...

Common ADHD Accommodations Fail to Boost Performance

Rethink ADHD Accommodations When it comes to ADHD, everyone ties the classic school accommodations to success. You give kids extra time, a quieter spot, and regular breaks, and you figure that's the magic formula, right? Well, hold onto your hats, because a fresh study out of Florida International University is flipping that script. Turns out, all those accommodations we...

Monotype's Inkwell: A Type Family with New Twists

Fresh Faces in the World of Type Out of the design trenches comes news that Monotype—the big cheese in type and tech—just rolled out four new styles in its well-liked Inkwell lineup. We're talking Inkwell Antique, Formal, Chancery, and Ornaments here. The idea? Give designers more room to play with tone. Let's chew on what this expansion means for folks rocking...

Lavazza 2027 Calendar: Moments of Pleasure Worldwide

Capturing Fleeting Joy Through the Lens In 2027, Lavazza sets the stage for an evocative exploration of human pleasure through its iconic calendar. Teaming up with photographers Jim Goldberg, Alex Majoli, and Paolo Pellegrin, the project spans three vibrant cities: New York, Lisbon, and Hong Kong. These masters of the lens invite us to pause and appreciate the understated...

Azitra Reports Q3 2026: Key Developments in Biopharma Pipeline

Unpacking Azitra's Recent Breakthroughs Azitra, Inc. galloped into the spotlight with their Q3 2026 financials and some hefty business updates. This isn’t just about dollars and cents; they've got some fascinating biotech news wrapped in. Riding High on ATR-COSF Ex Vivo Results All eyes are on Azitra’s ATR-COSF. The lab is lighting up with news — a 50% wrinkle...

Global Energy Storage Colloquium Sparks Collaboration

Setting the Stage for Energy Storage Breakthroughs Imagine a room bustling with brainpower, brimming with the promise of cleaner, more efficient energy. That's the scene at the inaugural Global Energy Storage Colloquium in Xiamen, where top-tier experts from all corners gathered to uncover what's next for energy storage. We're not just talking new gadgets but giant leaps...

APEC Summit 2026: Shenzhen in the Spotlight

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...